A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailprint

February 12, 2010

Physical, Psychological Symptoms Predict Viral Rebound Among ARV Adherent

People on antiretroviral (ARV) therapy with fully suppressed virus were more likely to see virus levels go up if they also reported physical symptoms—such as vomiting, or aches and pains—and psychological symptoms like anxiety and sadness, according to a study published online February 10 in the Journal of Acquired Immune Deficiency Syndromes.

A number of studies have found that people with psychological symptoms of depression and anxiety are more likely to have adherence problems and in turn to do less well on ARV therapy. Few researchers have explored, however, the potential link between psychological and physical symptoms and the loss of virological control in people who had achieved undetectable viral loads—and who presumably have not had significant adherence problems.

To explore this link, Fiona Lampe, PhD, from the University College London Medical School, and her colleagues compared reports of psychological and physical symptoms with records on viral load and CD4 count in 188 people living with HIV who had achieved a viral load less than 50 copies. All participants started the study with virus fully suppressed. Most of the participants were white men, and most had virus suppressed to less than 50 copies for at least one year. All were given a survey that asked questions about physical symptoms—such as pains and stomach problems—and psychological symptoms like anxiety, sadness and suicidal thoughts.

Of the 188 participants, 46 experienced a viral load rebound above 50 copies and 22 experienced a viral load rebound above 200 copies. Physical and psychological symptoms were also common. Twenty-five percent reported feeling sleepy and tired, 20 percent reported a lack of energy, 20 percent had a reduced sex drive, and 15 percent had diarrhea. Nearly half reported symptoms of depression and anxiety.

Lampe’s team found that the presence of physical and psychological symptoms had a significant association with the likelihood of viral rebound, and this link appeared to be independent of adherence. People with the greatest number of symptoms, in total, and who had symptoms that were more intense and more frequent were up to five times more likely to experience a virological rebound. People with psychological symptoms were almost four times as likely to have a rebound.

Although adherence was present in 8 percent of the people in the study, and was independently associated with virological rebound, the authors state that, “Non-adherence did not substantially explain the associations between symptoms and viral rebound.”

The authors acknowledge, however, that their sample size is small and that drug and alcohol use—about which they didn’t ask—could have influenced their results.

“Simple symptom inquiry conducted as part of routine clinical care may be valuable to identify patients at risk of future treatment failure,” they conclude, “and provide opportunity not only for assessing adherence but also for appropriate medical and psychological interventions to address physical symptoms and psychological distress.”

Search: adherence, psychological symptoms, physical symptoms, vomiting, nausea, depression, anxiety, Fiona Lampe, virological, viral rebound


Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 3 (of 3 total)    

Jeton Ademaj, Chelsea, NYC, 2010-02-17 03:51:58
Michael, it seems u don't realize that treatment failure COMMONLY happens for many reasons beyond adherence. the virus evolves, sometimes beyond the control of medication. It may well be that stress, anxiety and depression speed that process along, or they may be correlated with rebound but not the cause of it. There are more things in heaven and earth than are dreamt of in your philosophy. the ONLY messages that matter r the ones backed up by solid, peer-reviewed research.

michael, birmingham, 2010-02-16 11:36:10
This is nonsense. How does anyone fail a regimin if they are 100% adherent? This study sounds more like superstitious pseudoscience, and sends out the wrong message to otherwise adherant patients.

Kurtis, , 2010-02-16 10:01:35
I have tried to convince my doctors of this exact thing for 3 years, now.

comments 1 - 3 (of 3 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    CuteBoyinQns
    Jackson Heights
    New York


    sequoiamv
    San Jose
    California


    FoxyFresh57
    Bronx
    New York


    Fergie911
    Chicago
    Illinois
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.